Ikonisys S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 0.207213 million compared to EUR 0.141406 million a year ago. Net loss was EUR 1.02 million compared to EUR 0.113196 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 EUR | +0.69% | +0.69% | -7.05% |
06-12 | Ikonisys, Ulisse Biomed to Collaborate on New Cancer Diagnostic Technologies | MT |
06-03 | Ikonisys S.A. announced that it has received ?1.150001 million in funding | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.05% | 16.3M | |
-2.58% | 8.11B | |
+7.73% | 5.67B | |
+29.76% | 5.62B | |
-15.77% | 3.89B | |
+12.42% | 2.68B | |
-61.85% | 2.58B | |
-5.50% | 2.26B | |
+23.09% | 2.03B | |
-9.25% | 1.82B |
- Stock Market
- Equities
- ALIKO Stock
- News Ikonisys S.A.
- Ikonisys S.A. Reports Earnings Results for the Half Year Ended June 30, 2022